• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Saba Capital Management, L.P. returned $22,443,808 worth of shares to the company (2,170,581 units at $10.34)

    2/28/23 1:59:18 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials
    Get the next $IQMD alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Saba Capital Management, L.P.

    (Last) (First) (Middle)
    405 LEXINGTON AVENUE
    58TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Intelligent Medicine Acquisition Corp. [ IQMD ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    02/24/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/24/2023 D 2,170,581 D $10.34 0 I -
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Saba Capital Management, L.P.

    (Last) (First) (Middle)
    405 LEXINGTON AVENUE
    58TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Weinstein Boaz

    (Last) (First) (Middle)
    405 LEXINGTON AVENUE
    58TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    Explanation of Responses:
    William Manzolillo 02/28/2023
    Boaz Weinstein 02/28/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $IQMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IQMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IQMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider Goldman Sachs Group Inc claimed ownership of 200,000 shares

    3 - Intelligent Medicine Acquisition Corp. (0001850051) (Issuer)

    4/27/23 7:00:05 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    SEC Form 4: Saba Capital Management, L.P. returned $22,443,808 worth of shares to the company (2,170,581 units at $10.34)

    4 - Intelligent Medicine Acquisition Corp. (0001850051) (Issuer)

    2/28/23 1:59:18 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    SEC Form 4 filed by Intelligent Medicine Sponsor Llc

    4 - Intelligent Medicine Acquisition Corp. (0001850051) (Issuer)

    2/10/23 4:20:27 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    $IQMD
    SEC Filings

    View All

    SEC Form 15-12G filed by Intelligent Medicine Acquisition Corp.

    15-12G - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)

    5/12/23 4:40:26 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    SEC Form 25-NSE filed by Intelligent Medicine Acquisition Corp.

    25-NSE - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)

    5/2/23 1:37:12 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    Intelligent Medicine Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Intelligent Medicine Acquisition Corp. (0001850051) (Filer)

    4/26/23 8:45:34 AM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    $IQMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares

    Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD) (the "Company"), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that because the Company does not believe it will be able to consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (the "Charter"), the Company intends to dissolve and liquidate in accordance with the provisions of the Charter, and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximate

    4/26/23 8:30:00 AM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders

    Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD) (the "Company") announced today that it has postponed the Company's Special Meeting of Stockholders to be held on February 3, 2023, at 9:30 a.m. Eastern Time until February 8, 2023, at 9:30 a.m. Eastern Time. The postponed Special Meeting will be completely virtual, and stockholders will be able to attend the special meeting online, vote and submit questions by visiting https://www.cstproxy.com/iqmdspac/2023. There will be no change in the record date as a result of this postponement or the date by which stockholders must have elected to redeem their public shares, and proxies tendered prior to the postponed date will not need to be voted

    2/3/23 5:00:00 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    Kroll Appoints Patience Marime-Ball as Senior Advisor to Kroll's ESG Advisory Services

    Kroll, the leading provider of data, technology and insights related to risk, governance and growth, announced today Patience Marime-Ball will be a Senior Advisor to Kroll's Environmental, Social and Governance (ESG) Advisory Services Committee. Kroll provides an extensive range of advisory support and technology solutions to address growing ESG challenges, create sustainable value and growth, and effectively manage risk. Marime-Ball will play a critical role advising Kroll and its clients on how to drive meaningful changes that will help benefit people and the planet. "We're excited to welcome Patience as a new Senior Advisor to Kroll on ESG," said Jake Silverman, Chief Executive Officer

    6/14/22 9:00:00 AM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    $IQMD
    Leadership Updates

    Live Leadership Updates

    View All

    Kroll Appoints Patience Marime-Ball as Senior Advisor to Kroll's ESG Advisory Services

    Kroll, the leading provider of data, technology and insights related to risk, governance and growth, announced today Patience Marime-Ball will be a Senior Advisor to Kroll's Environmental, Social and Governance (ESG) Advisory Services Committee. Kroll provides an extensive range of advisory support and technology solutions to address growing ESG challenges, create sustainable value and growth, and effectively manage risk. Marime-Ball will play a critical role advising Kroll and its clients on how to drive meaningful changes that will help benefit people and the planet. "We're excited to welcome Patience as a new Senior Advisor to Kroll on ESG," said Jake Silverman, Chief Executive Officer

    6/14/22 9:00:00 AM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    $IQMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Intelligent Medicine Acquisition Corp.

    SC 13G - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)

    2/14/24 6:00:38 AM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Intelligent Medicine Acquisition Corp. (Amendment)

    SC 13G/A - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)

    4/13/23 8:02:27 AM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13D filed by Intelligent Medicine Acquisition Corp.

    SC 13D - Intelligent Medicine Acquisition Corp. (0001850051) (Subject)

    2/21/23 4:31:28 PM ET
    $IQMD
    Consumer Electronics/Appliances
    Industrials